Scleroderma is a rare disease of the autoimmune system that many people haven’t heard of. Yet recognizing the symptoms can help you get treatment faster – and provide the best chance for a successful outcome.
Swiss pharmaceutical company Actelion gets FDA approval on new drug for use in treating Group 1 pulmonary arterial hypertension. Compared with earlier drugs, macitentan caused side effects in fewer patients.
Register for Online Chat Ask questions and get answers about Marfan syndrome and aorta disease from Cleveland Clinic physicians during a live webchat Monday, Oct. 8, 2012, at noon (ET). Marfan [...]
Ask questions and get answers about pulmonary hypertension from Cleveland Clinic physicians during a live webchat Wednesday, Sept. 26, 2012, at noon (ET).